The Food and Drug Administration (FDA) announced Friday it had cleared a new test to help diagnose adults with Alzheimer’s ...

Ken Cohen, a physician and Optum’s executive director of translational research, said Thursday at a conference organized by ...

Important changes are coming to 42 CFR Part 2 (Part 2), which deals with the confidentiality of patients’ substance use disorder (SUD) records.

The potential of biotech-powered consumer health is as sensitive as it is expansive. When it comes to consumer education, ...

Years ago, before Texas effectively banned elective abortions in the wake of the U.S. Supreme Court’s ruling overturning its previous Roe v. Wade decision, state lawmakers passed a provision requiring ...